Lansen Pharmaceutical Holdings Overview

  • Founded
  • 2001
Founded
  • Status
  • Public
  • Employees
  • 645
Employees
  • Stock Symbol
  • 00503
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $0.25
  • (As of Monday Closing)

Lansen Pharmaceutical Holdings General Information

Description

Lansen Pharmaceutical Holdings Ltd is an investment holding company engaged in research and development, production, and sales of traditional Chinese medicines. The operating segments of the group are Pharmaceuticals, Cosmetics products, and Healthcare products. It generates a majority of revenue from the Pharmaceuticals segment, which includes development, production, and sale of specialty pharmaceuticals mainly used in the field of rheumatology and dermatology and other pharmaceuticals. The company's products include Xinshi indeed, Pavlin, Keshu syrup, Bazhen granules, Xinnaojian Capsule, Yahao-Dingbo Cream, and others. The group operates in the PRC and internationally, of which prime revenue is derived from the operations in PRC.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Holding Companies
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
HKG
Primary Office
  • 12/F., Li Po Chun Chambers
  • Suites 1203-4, 189 Des Voeux Road
  • Central
  • Hong Kong
+852 2828 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lansen Pharmaceutical Holdings Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.25 $0.26 $0.06 - $0.29 $104M 2.02M $0.28

Lansen Pharmaceutical Holdings Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 74,359 120,529 120,631 148,481
Revenue 54,881 54,257 56,872 89,484
EBITDA 122,839 26,376 9,421 24,046
Net Income 110,008 18,349 160 15,629
Total Assets 251,857 183,959 201,913 227,745
Total Debt 32,190 61,414 87,224 99,135
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lansen Pharmaceutical Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lansen Pharmaceutical Holdings Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 31-Dec-2018 000000000 00000000 00.000 Biotechnology
Zhejiang Starry Pharmaceutical Company 01-Jan-2010 Corporate 000.00 Pharmaceuticals
To view Lansen Pharmaceutical Holdings’s complete investments history, request access »